AJU Pharm

Privately held: no public share price · South Korea

Assets

(2 total)
2Total Assets
0Approved
2Phase 3 / Filed
0Phase 1–2 / Early
2Diseases
Quick filter:
Showing 2 of 2 assets
Target & Modality
Phase 3
SGLT2;DPP-4Small molecule
Type 2 Diabetes
Phase 3
Angiotensin II receptor / Calcium channel / Thiazide-like diureticSmall molecule
Hypertension

Upcoming events

No upcoming trial completions or earnings dates on record for this company's assets.

Financial reports

No financial reports recorded.